EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Challenges of estimating treatment effects after a positive interim analysis

Yu Yang Soon, Ian C Marschner, Manjula Schou, Christopher J Sweeney, Ian D Davis, Martin R Stockler, Andrew J Martin

European Journal of Cancer · 2024-09 · 209 · 114230

DOI: 10.1016/j.ejca.2024.114230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2024-09. Verfasst von Yu Yang Soon und 6 weiteren Autor:innen. Beteiligte Einrichtung: NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Radiation Oncology, National University Cancer Institute, S…. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicNeoplasmsHumansBiasTreatment OutcomeResearch DesignData Interpretation, StatisticalProportional Hazards Models

Stichwörter der Autor:innen

Interim analysisNon-proportional hazardsOverestimation biasRandomized clinical trials

Autor:innen und Institutionen

  • NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore; Department of Medicine, Yong Loo Lin School of Me…
  • NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia.
  • South Australian Immunogenomics Cancer Institute, Adelaide, SA, Australia; Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia; Australian and New Zealand Urogenital and Prostate Canc…
  • Eastern Health Clinical School, Monash University, Melbourne, VIC, Australia; Eastern Health, Melbourne, VIC, Australia; Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Australia.
  • NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; Department of Medical Oncology, Concord Repatriation General Hospital, Sydney, NSW, Australia; Department of Medical Oncology, Chris O'Brien Li…
  • NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia; UQ Centre for Clinical Research, University of Queensland, Brisbane, QLD, Australia; Australian and New Zealand Urogenital and Prostate Cancer…

Zitieren

APA

Soon, Y. Y., Marschner, I. C., Schou, M., Sweeney, C. J., Davis, I. D., Stockler, M. R., & Martin, A. J. (2024). Challenges of estimating treatment effects after a positive interim analysis. European Journal of Cancer, 209, 114230. https://doi.org/10.1016/j.ejca.2024.114230

Vancouver

Soon YY, Marschner IC, Schou M, Sweeney CJ, Davis ID, Stockler MR, et al. Challenges of estimating treatment effects after a positive interim analysis. European Journal of Cancer. 2024;209:114230. doi:10.1016/j.ejca.2024.114230

BibTeX
@article{Soon2024,
  author = {Soon, Yu Yang and Marschner, Ian C and Schou, Manjula and Sweeney, Christopher J and Davis, Ian D and Stockler, Martin R and Martin, Andrew J},
  title = {Challenges of estimating treatment effects after a positive interim analysis},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {209},
  pages = {114230},
  doi = {10.1016/j.ejca.2024.114230}
}
Kostenlos starten →